Jan Andersson mainly investigates Immunology, Internal medicine, Cytotoxic T cell, Virology and Cytokine. Antigen, CD8, Immune system, Chemokine and Lymphocyte are among the areas of Immunology where the researcher is concentrating his efforts. His Internal medicine research incorporates elements of Gastroenterology and Surgery.
The various areas that Jan Andersson examines in his Cytotoxic T cell study include T cell and Peripheral blood mononuclear cell. His Virology research includes elements of Tumor necrosis factor alpha, Interleukin 12, Lymphatic system and Dendritic cell. Many of his research projects under Cytokine are closely connected to Connective tissue disease with Connective tissue disease, tying the diverse disciplines of science together.
The scientist’s investigation covers issues in Immunology, Cytokine, Immune system, Internal medicine and Antigen. His Immunology study combines topics from a wide range of disciplines, such as Cytotoxic T cell, Tuberculosis and Virology. His biological study spans a wide range of topics, including Cell, Superantigen, Chemokine, Peripheral blood mononuclear cell and Immunotherapy.
His Immune system research incorporates themes from Lymphatic system and In vivo. In general Internal medicine, his work in Transplantation is often linked to Placebo linking many areas of study. His studies in Antigen integrate themes in fields like Molecular biology, Antibody and CD40.
His main research concerns Immunology, Tuberculosis, Immune system, Mycobacterium tuberculosis and Positron emission tomography. His Immunology research is multidisciplinary, relying on both Disease and Virology. Jan Andersson interconnects vitamin D deficiency, Case-control study, Immunity and Vaccination in the investigation of issues within Tuberculosis.
His studies in Immune system integrate themes in fields like Myeloid and Pathogenesis. His study in Mycobacterium tuberculosis is interdisciplinary in nature, drawing from both Interleukin, Peripheral blood mononuclear cell, Antibody and Lymphocyte. His Positron emission tomography study combines topics from a wide range of disciplines, such as Pathology, Benzodiazepine and In vivo, Radioligand.
His primary areas of investigation include Immunology, Tuberculosis, Mycobacterium tuberculosis, Immune system and Virology. Immunology and Shigellosis are two areas of study in which Jan Andersson engages in interdisciplinary research. The various areas that he examines in his Tuberculosis study include Peripheral blood mononuclear cell and Cytokine.
His biological study spans a wide range of topics, including Chemokine, Bronchoalveolar lavage and CCL5. His Immune system study combines topics in areas such as Disease and Pathogenesis. Jan Andersson combines subjects such as Foreskin, Langerin and C-type lectin with his study of Virology.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
HMG-1 as a Late Mediator of Endotoxin Lethality in Mice
Haichao Wang;Ona Bloom;Minghuang Zhang;Jaideep M. Vishnubhakat.
Intravenous Immunoglobulin G Therapy in Streptococcal Toxic Shock Syndrome: A European Randomized, Double-Blind, Placebo-Controlled Trial
Jessica Darenberg;Nahla Ihendyane;Jan Sjölin;Ewa Aufwerber.
Clinical Infectious Diseases (2003)
Increased production of IL-7 accompanies HIV-1–mediated T-cell depletion: implications for T-cell homeostasis
Laura A. Napolitano;Robert M. Grant;Steven G. Deeks;Diane Schmidt.
Nature Medicine (2001)
Selective induction of DNA synthesis in T and B lymphocytes
Jan Andersson;Jan Andersson;Göran Möller;Göran Möller;Olof Sjöberg;Olof Sjöberg.
Cellular Immunology (1972)
Persistent elevation of high mobility group box-1 protein (HMGB1) in patients with severe sepsis and septic shock*
Jonas Sundén-Cullberg;Anna Norrby-Teglund;Ari Rouhiainen;Heikki Rauvala.
Critical Care Medicine (2005)
Cutting Edge: The Prevalence of Regulatory T Cells in Lymphoid Tissue Is Correlated with Viral Load in HIV-Infected Patients
Jan Andersson;Adriano Boasso;Jakob Nilsson;Rui Zhang.
Journal of Immunology (2005)
Ribavirin treatment for chronic hepatitis C.
O. Reichard;J. Andersson;R. Schvarcz;O. Weiland.
The Lancet (1991)
High mobility group 1 B‐box mediates activation of human endothelium
C. J. Treutiger;G. E. Mullins;A.-S. M. Johansson;A. Rouhiainen;A. Rouhiainen.
Journal of Internal Medicine (2003)
Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection.
Judy Lieberman;Premlata Shankar;N. Manjunath;Jan Andersson.
Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection
Edwin Leeansyah;Anupama Ganesh;Máire F. Quigley;Anders Sönnerborg.
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: